Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma.

Clin Sarcoma Res · 2020 · PMC7453529 · PMID 32864096

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In this case of relapsed disease post three lines of chemotherapy, this PFS is especially highly significant and indicates the benefit of trabectedin in relapsed/refractory setting.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.